Medtronic stops distribution, sale of heart device over safety concerns

[June 03, 2021]  (Reuters) - Medtronic Plc said on Thursday it was stopping the distribution and sale of its heart device HVAD System due to safety concerns.

The company earlier informed physicians that the HVAD pump may experience a delay to restart or a failure to restart after it was stopped.

Pump restart failure can potentially worsen a patient's heart condition, lead to a heart attack, require hospitalization and result in death, Medtronic said.

(Reporting by Dania Nadeem in Bengaluru; Editing by Aditya Soni)

[© 2021 Thomson Reuters. All rights reserved.]

Copyright 2021 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content